Two HCC models’ different expression of FGF19 and FGFRs were used to determine the expression levels of regulators of angiogenesis such as PDGF-AA, CYR61, VEGF, TGF- β1, FGFs, and HGF [26] following treatments. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.